GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bedrocan Cannabis Corp (FRA:8BC) » Definitions » EV-to-EBITDA

Bedrocan Cannabis (FRA:8BC) EV-to-EBITDA : -39.29 (As of May. 22, 2024)


View and export this data going back to . Start your Free Trial

What is Bedrocan Cannabis EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bedrocan Cannabis's enterprise value is €35.52 Mil. Bedrocan Cannabis's EBITDA for the trailing twelve months (TTM) ended in Apr. 2015 was €-0.90 Mil. Therefore, Bedrocan Cannabis's EV-to-EBITDA for today is -39.29.

The historical rank and industry rank for Bedrocan Cannabis's EV-to-EBITDA or its related term are showing as below:

FRA:8BC's EV-to-EBITDA is not ranked *
in the Biotechnology industry.
Industry Median: 10.52
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-22), Bedrocan Cannabis's stock price is €0.49. Bedrocan Cannabis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2015 was €-0.173. Therefore, Bedrocan Cannabis's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bedrocan Cannabis EV-to-EBITDA Historical Data

The historical data trend for Bedrocan Cannabis's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bedrocan Cannabis EV-to-EBITDA Chart

Bedrocan Cannabis Annual Data
Trend Jan13 Jan14 Jan15
EV-to-EBITDA
- -2.21 -96.29

Bedrocan Cannabis Quarterly Data
Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.45 - -68.44 -96.29 -41.68

Competitive Comparison of Bedrocan Cannabis's EV-to-EBITDA

For the Biotechnology subindustry, Bedrocan Cannabis's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bedrocan Cannabis's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bedrocan Cannabis's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bedrocan Cannabis's EV-to-EBITDA falls into.



Bedrocan Cannabis EV-to-EBITDA Calculation

Bedrocan Cannabis's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=35.515/-0.904
=-39.29

Bedrocan Cannabis's current Enterprise Value is €35.52 Mil.
Bedrocan Cannabis's EBITDA for the trailing twelve months (TTM) ended in Apr. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.90 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bedrocan Cannabis  (FRA:8BC) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bedrocan Cannabis's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.49/-0.173
=At Loss

Bedrocan Cannabis's share price for today is €0.49.
Bedrocan Cannabis's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.173.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bedrocan Cannabis EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bedrocan Cannabis's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bedrocan Cannabis (FRA:8BC) Business Description

Traded in Other Exchanges
N/A
Address
POCML 2 Inc is a capital pool company. The Company will not carry on any business other than the identification and evaluation of assets or businesses with a view to completing a proposed Qualifying Transaction.

Bedrocan Cannabis (FRA:8BC) Headlines

No Headlines